GlassScriptPhysician profile
Prisca Nwizugbo
NPI 1184922874
$3,328.78
in general payments reported to CMS, 2019-2025
19 companies · $581 in 2025
The $581 reported for 2025 was more than what 75% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $600 · 2022: $982 · 2023: $866 · 2024: $300 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $981.19 | 2021-2025 | Spravato |
| Neurocrine Biosciences, INC. | $957.46 | 2021-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $243.08 | 2022-2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $166.99 | 2021-2024 | Trintellix |
| Abbvie INC. | $159.86 | 2021-2025 | |
| Supernus Pharmaceuticals, INC. | $153.40 | 2022-2025 | Qelbree, Qelbree |
| Otsuka America Pharmaceutical, INC. | $129.41 | 2021-2023 | Nuedexta, Abilify Maintena, Rexulti |
| Sunovion Pharmaceuticals INC. | $87.57 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $85.00 | 2021-2025 | Fanapt |
| Lundbeck LLC | $81.26 | 2021-2023 | Rexulti |
| Corium, LLC | $64.59 | 2022-2023 | Azstarys |
| Tris Pharma INC | $40.75 | 2023-2024 | Dyanavel Xr |
| Alkermes, INC. | $38.14 | 2024-2025 | Aristada, Lybalvi |
| Merck Sharp & Dohme LLC | $35.31 | 2022 | |
| Axsome Therapeutics, INC. | $31.00 | 2023 | Auvelity |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $21.13 | 2023 | Aplenzin |
| Jazz Pharmaceuticals INC. | $19.99 | 2021 | |
| Harmony Biosciences LLC | $17.68 | 2023 | Wakix |
| Collegium Pharmaceutical, INC. | $14.97 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prisca Nwizugbo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.